Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 16 studies | 29% ± 9% | |
brain | 13 studies | 39% ± 19% | |
intestine | 9 studies | 27% ± 13% | |
peripheral blood | 6 studies | 28% ± 11% | |
eye | 6 studies | 32% ± 11% | |
pancreas | 4 studies | 50% ± 23% | |
kidney | 4 studies | 26% ± 9% | |
uterus | 4 studies | 32% ± 11% | |
lymph node | 4 studies | 28% ± 16% | |
breast | 4 studies | 32% ± 10% | |
placenta | 3 studies | 22% ± 6% | |
prostate | 3 studies | 31% ± 7% | |
liver | 3 studies | 41% ± 33% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 7650.71 | 966 / 966 | 100% | 208.52 | 527 / 527 |
breast | 100% | 6978.11 | 459 / 459 | 100% | 251.37 | 1117 / 1118 |
lung | 100% | 9754.43 | 577 / 578 | 100% | 197.23 | 1155 / 1155 |
skin | 99% | 5677.74 | 1792 / 1809 | 100% | 181.18 | 471 / 472 |
esophagus | 99% | 7594.53 | 1428 / 1445 | 100% | 185.28 | 183 / 183 |
uterus | 99% | 6059.49 | 168 / 170 | 100% | 220.79 | 459 / 459 |
brain | 99% | 26239.84 | 2610 / 2642 | 100% | 288.14 | 705 / 705 |
thymus | 98% | 5928.68 | 643 / 653 | 100% | 134.22 | 603 / 605 |
kidney | 98% | 5801.28 | 87 / 89 | 100% | 236.98 | 900 / 901 |
bladder | 95% | 7068.33 | 20 / 21 | 99% | 181.66 | 501 / 504 |
prostate | 96% | 5491.80 | 235 / 245 | 99% | 97.66 | 495 / 502 |
ovary | 94% | 4308.66 | 169 / 180 | 100% | 155.17 | 430 / 430 |
stomach | 94% | 5370.21 | 337 / 359 | 100% | 209.32 | 286 / 286 |
adrenal gland | 91% | 4145.81 | 235 / 258 | 96% | 252.33 | 221 / 230 |
pancreas | 79% | 3287.56 | 260 / 328 | 99% | 237.13 | 177 / 178 |
liver | 62% | 2184.06 | 139 / 226 | 98% | 109.24 | 397 / 406 |
blood vessel | 100% | 18610.09 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 166.06 | 29 / 29 |
spleen | 100% | 5263.70 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 200.43 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 70.28 | 1 / 1 |
adipose | 100% | 9012.88 | 1203 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 118.14 | 79 / 80 |
heart | 92% | 4401.58 | 792 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 87% | 4632.41 | 804 / 929 | 0% | 0 | 0 / 0 |
muscle | 80% | 3012.12 | 642 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045664 | Biological process | regulation of neuron differentiation |
GO_2000649 | Biological process | regulation of sodium ion transmembrane transporter activity |
GO_0002028 | Biological process | regulation of sodium ion transport |
GO_0007165 | Biological process | signal transduction |
GO_0006886 | Biological process | intracellular protein transport |
GO_0006713 | Biological process | glucocorticoid catabolic process |
GO_0042921 | Biological process | nuclear receptor-mediated glucocorticoid signaling pathway |
GO_0048167 | Biological process | regulation of synaptic plasticity |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0099171 | Biological process | presynaptic modulation of chemical synaptic transmission |
GO_0021762 | Biological process | substantia nigra development |
GO_0086010 | Biological process | membrane depolarization during action potential |
GO_0008104 | Biological process | protein localization |
GO_0050774 | Biological process | negative regulation of dendrite morphogenesis |
GO_0098793 | Cellular component | presynapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0150048 | Cellular component | cerebellar granule cell to Purkinje cell synapse |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0014704 | Cellular component | intercalated disc |
GO_0019899 | Molecular function | enzyme binding |
GO_0035259 | Molecular function | nuclear glucocorticoid receptor binding |
GO_0005159 | Molecular function | insulin-like growth factor receptor binding |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0044325 | Molecular function | transmembrane transporter binding |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0017080 | Molecular function | sodium channel regulator activity |
GO_0005515 | Molecular function | protein binding |
GO_0003779 | Molecular function | actin binding |
Gene name | YWHAH |
Protein name | Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta 14-3-3 protein eta (Protein AS1) |
Synonyms | YWHA1 |
Description | FUNCTION: Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner. Negatively regulates the kinase activity of PDPK1. . |
Accessions | A2IDB1 Q04917 ENST00000443669.5 F8WEB6 A2IDB2 ENST00000397492.1 ENST00000420430.1 ENST00000248975.6 |